v3.26.1
Stockholders’ Deficit (Tables)
3 Months Ended
Apr. 30, 2026
Equity [Abstract]  
Schedule of Reserved Shares of Common Stock
The Company has reserved shares of its common stock for future issuance as follows (in thousands):
April 30,January 31,
20262026
2014 Stock Option and Grant Plan:
Outstanding stock options8,818 8,970 
Outstanding restricted stock units6,200 9,227 
2024 Equity Incentive Plan:
Outstanding restricted stock units16,898 12,294 
Shares available for future issuance under the 2024 Plan64,061 58,406 
2024 Employee Stock Purchase Plan6,571 5,090 
Total shares of common stock reserved102,548 93,987 
Schedule of Stock Options Roll Forward
A summary of the stock option activity and related information is as follows:
Number of
Options
Weighted-
Average
Exercise Price
Weighted-
Average
Remaining
Contractual
Term (years)
Aggregate
Intrinsic
Value (in
thousands)
Outstanding as of January 31, 20268,970,353 $29.20 7.6$239,954 
Granted— — — — 
Exercised(152,660)4.21 — 7,200 
Cancelled— — — — 
Outstanding as of April 30, 20268,817,693 $29.63 7.4$207,630 
Vested and exercisable as of April 30, 20263,649,981 $26.28 6.7$98,168 
Schedule of Nonvested Restricted Stock Units Activity
A summary of the RSU activity and related information is as follows:
Number of
RSUs
Weighted-Average
Grant Date Fair Value
Unvested as of January 31, 202621,480,571 $48.73 
Granted6,648,891 49.04 
Vested(2,840,496)35.17 
Forfeited(2,191,311)43.37 
Outstanding as of April 30, 202623,097,655 $51.00 
Schedule of the Assumptions Used in Estimating Fair Value of ESPP
The Company estimated the fair value of ESPP purchase rights using a Black-Scholes option-pricing model with the following assumptions:
Three Months Ended April 30,
20262025
Expected term (in years)
0.5 - 2.0
0.5 - 2.0
Expected volatility
59.4% - 61.2%
59.0% - 64.7%
Risk-free interest rate
3.8% - 3.8%
3.9% - 4.3%
Dividend yield
Schedule of Stock-Based Compensation Expense
Total stock-based compensation expense included in the Company’s unaudited condensed consolidated statements of operations was as follows (in thousands):
Three Months Ended April 30,
20262025
Cost of revenue
Subscription$4,631 $3,968 
Other634 857 
Research and development33,026 19,812 
Sales and marketing16,331 24,144 
General and administrative18,746 24,759 
Total stock-based compensation expense$73,368 $73,540